March 2017

  • All
  • Aerospace
  • Automotive
  • Banking & Payments
  • Business Fundamentals
  • Construction
  • Consumer
  • Defense & Security
  • Disruptor
  • Energy
  • Foodservice
  • Influencer
  • Insurance
  • Medical Devices
  • Mining
  • Oil & Gas
  • Packaging
  • Pharma
  • Power
  • Retail
  • Technology
  • Travel & Tourism

Following the news that the Food and Drug Administration (FDA) has approved Vyepti for the prevention of migraines in adults, Philippa Salter, Neurology and Ophthalmology Analyst at GlobalData, a leading data and analytics company, offers her view: “Vyepti becomes the latest FDA approved drug for prevention of migraines in adults, following the approval of Amgen’s Aimovig, Eli Lilly’s Emgality and...

Leading data and analytics company GlobalData has revealed its predictions for 2020 across the technology, media and telecoms (TMT) industry. The company’s latest thematic research report, ‘TMT...